{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:14:41Z","timestamp":1792653281684,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.urolonc.2021.02.016","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T13:06:52Z","timestamp":1616072812000},"page":"782.e1-782.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Safety and side effects of transperineal prostate biopsy without antibiotic prophylaxis"],"prefix":"10.1016","volume":"39","author":[{"given":"August","family":"Sigle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Suarez-Ibarrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Pudimat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Michaelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula A.","family":"Jilg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiusz","family":"Miernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus T.","family":"Grabbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Schultze-Seemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gratzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2021.02.016_bib0001","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","article-title":"Complications after systematic, random, and image-guided prostate biopsy","volume":"71","author":"Borghesi","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0002","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG Guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2012.11.015","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"189","author":"Nam","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00345-019-02837-0","article-title":"Antibiotic resistance, hospitalizations, and mortality related to prostate biopsy: first report from the Norwegian Patient Registry","volume":"38","author":"Johansen","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12957-019-1573-0","article-title":"Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Xiang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2016.07.007","article-title":"Transperineal versus transrectal MRI\/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer","volume":"15","author":"Pepe","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41391-020-0204-8","article-title":"TREXIT 2020\": why the time to abandon transrectal prostate biopsy starts now","volume":"23","author":"Grummet","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0008","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2020.10.019","article-title":"European Association of Urology Position Paper on the prevention of infectious complications following prostate biopsy","volume":"79","author":"Pilatz","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2384894","article-title":"Diagnostic accuracy of robot-guided, software based transperineal MRI\/TRUS fusion biopsy of the prostate in a high risk population of previously biopsy negative men","volume":"2016","author":"Kroenig","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0010","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/bju.12132","article-title":"Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics: A standardization approach for transperineal prostate biopsies","volume":"112","author":"Kuru","year":"2013","journal-title":"BJU International"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0011","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.eururo.2011.12.058","article-title":"Infectious complications and hospital admissions after prostate biopsy in a European randomized trial","volume":"61","author":"Loeb","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0012","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11255-014-0904-x","article-title":"Does metabolic syndrome increase the risk of infective complications after prostate biopsy? A critical evaluation","volume":"47","author":"Sahin","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0013","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0014","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bju.12536","article-title":"Sepsis and 'superbugs': should we favour the transperineal over the transrectal approach for prostate biopsy?","volume":"114","author":"Grummet","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/bju.12282","article-title":"Indications, results and safety profile of transperineal sector biopsies (TPSB) of the prostate: a single centre experience of 634 cases","volume":"114","author":"Vyas","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0016","article-title":"Risk factors for infection complications after transrectal ultrasound-guided transperineal prostate biopsy","author":"Ding","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0017","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1007\/s00345-019-02992-4","article-title":"Transperineal prostate biopsy with cognitive magnetic resonance imaging\/biplanar ultrasound fusion: description of technique and early results","volume":"38","author":"Gorin","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0018","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41391-019-0201-y","article-title":"Feasibility of freehand MRI\/US cognitive fusion transperineal biopsy of the prostate in local anaesthesia as in-office procedure-experience with 400 patients","volume":"23","author":"Wetterauer","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0019","first-page":"1225","article-title":"[Initial results of perineal MRI\/ultrasound fusion biopsies under local anesthesia without standard perioperative antibiotic prophylaxis]","volume":"59","author":"Gunzel","year":"2020","journal-title":"Der Urologe Ausg A"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0020","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.eururo.2008.03.033","article-title":"Antibiotic prophylaxis in urologic procedures: a systematic review","volume":"54","author":"Bootsma","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0021","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0022-5347(05)67996-7","article-title":"Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores","volume":"163","author":"Naughton","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0022","doi-asserted-by":"crossref","first-page":"e13257","DOI":"10.5812\/iranjradiol.13257","article-title":"Prostate biopsy using transrectal ultrasonography; the optimal number of cores regarding cancer detection rate and complications","volume":"12","author":"Ghafoori","year":"2015","journal-title":"Iran J Radiol"},{"key":"10.1016\/j.urolonc.2021.02.016_bib0023","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.urology.2013.02.019","article-title":"Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores","volume":"81","author":"Pepe","year":"2013","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921000788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921000788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:21:46Z","timestamp":1761042106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921000788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1078143921000788"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.02.016","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and side effects of transperineal prostate biopsy without antibiotic prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}